A major breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently lost in many kinds of malignancies, causing https://guidemysocial.com/story7459675/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-management